Novel regenerative thereapeutics using organoids
Employees: 51-200
Investors 3
Mentions in press and media 1
| Date | Title | Description |
| 21.02.2024 | Leading the Way: The CMTA Invests More Than $200K in Cutting-Edge CMT1A Organoid Research | The CMTA's new $200K+ investment accelerates CMT1A organoid research, revolutionizing treatment evaluation for Charcot-Marie-Tooth disease (CMT) By investing in cutting-edge methodologies like organoid modeling, the CMTA is laying the groun... |